🇺🇸 FDA
Patent

US 11229636

Substituted tetrahydroquinolinone compounds as ROR gamma modulators

granted A61KA61K31/4709A61K31/4985

Quick answer

US patent 11229636 (Substituted tetrahydroquinolinone compounds as ROR gamma modulators) held by Aurigene Discovery Technologies Limited expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
41
CPC classes
A61K, A61K31/4709, A61K31/4985, A61K31/501, A61K31/506